Antidepressant controlled trial for negative symptoms in schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial.

Antidepressant controlled trial for negative symptoms in schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial.

<h4>Background</h4> <p>Negative symptoms of schizophrenia represent deficiencies in emotional responsiveness, motivation, socialisation, speech and movement. When persistent, they are held to account for much of the poor functional outcomes associated with schizophrenia. There are...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Barnes, T, Leeson, V, Paton, C, Costelloe, C, Simon, J, Kiss, N, Osborn, D, Killaspy, H, Craig, T, Lewis, S, Keown, P, Ismail, S, Crawford, M, Baldwin, D, Lewis, G, Geddes, J, Kumar, M, Pathak, R, Taylor, S
Format:	Journal article
Język:	English
Wydane:	National Institute for Health Research 2016

Podobne zapisy

Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial
od: Thomas RE Barnes, i wsp.
Wydane: (2016-04-01)

Long-term antidepressant treatment for negative symptoms in schizophrenia: the actions study
od: Barnes, T, i wsp.
Wydane: (2017)

Disclosing the potential impact of placebo controls in antidepressant trials
od: Stephanie C. Chen, i wsp.
Wydane: (2015-06-01)

Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness
od: Thomas RE Barnes, i wsp.
Wydane: (2017-09-01)

Adverse effects from antidepressant treatment: randomised controlled trial of 601 depressed individuals.
od: Crawford, A, i wsp.
Wydane: (2014)

Adverse effects from antidepressant treatment: Randomised controlled trial of 601 depressed individuals
od: Crawford, A, i wsp.
Wydane: (2014)

60 years of placebo-controlled antipsychotic drug trials in acute schizophrenia: Meta-regression of predictors of placebo response
od: Leucht, S, i wsp.
Wydane: (2018)

HOW IMPORTANT IS PLACEBO IN ANTIDEPRESSANT TRIALS?
od: Cipriani, A
Wydane: (2010)

Group art therapy as an adjunctive treatment for people with schizophrenia: a randomised controlled trial (MATISSE)
od: MJ Crawford, i wsp.
Wydane: (2012-02-01)

Impact of reporting bias in network meta-analysis of antidepressant placebo-controlled trials.
od: Ludovic Trinquart, i wsp.
Wydane: (2012-01-01)

Comparative efficacy of placebos in short-term antidepressant trials for major depression: a secondary meta-analysis of placebo-controlled trials
od: Lisa Holper, i wsp.
Wydane: (2020-09-01)

Antidepressants Trial in Parkinson's Disease (ADepT-PD): protocol for a randomised placebo-controlled trial on the effectiveness of escitalopram and nortriptyline on depressive symptoms in Parkinson’s disease
od: A Schrag, i wsp.
Wydane: (2022-12-01)

Severity of depression and response to antidepressants: GENPOD randomised controlled trial.
od: Wiles, N, i wsp.
Wydane: (2012)

Attitudes toward Placebo-Controlled Clinical Trials of Patients with Schizophrenia in Japan.
od: Norio Sugawara, i wsp.
Wydane: (2015-01-01)

Antidepressants for bipolar depression: a systematic review of randomized, controlled trials.
od: Gijsman, H, i wsp.
Wydane: (2004)

Polymorphism of the 5-HT transporter and response to antidepressants: randomised controlled trial.
od: Lewis, G, i wsp.
Wydane: (2011)

Individual differences in response to antidepressants: a meta-analysis of placebo-controlled randomized clinical trials
od: Maslej, MM, i wsp.
Wydane: (2021)

Randomized controlled trials for schizophrenia: study designs targeted to distinct goals.
od: Stroup, T, i wsp.
Wydane: (2008)

Efficacy of antidepressants over placebo is similar in two-armed versus three-armed or more-armed randomized placebo-controlled trials.
od: Ogawa, Y, i wsp.
Wydane: (2017)

A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia
od: Shiraishi Tetsuya, i wsp.
Wydane: (2010-06-01)

Study of the use of antidepressants for depression in dementia: the HTA-SADD trial – a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine
od: S Banerjee, i wsp.
Wydane: (2013-02-01)

Immunomodulatory Effects of Probiotic Supplementation in Schizophrenia Patients: A Randomized, Placebo-Controlled Trial
od: Jakub Tomasik, i wsp.
Wydane: (2015-06-01)

Immunomodulatory Effects of Probiotic Supplementation in Schizophrenia Patients: A Randomized, Placebo-Controlled Trial
od: Jakub Tomasik, i wsp.
Wydane: (2015-01-01)

Allowing for non-adherence to treatment in a randomized controlled trial of two antidepressants (citalopram versus reboxetine): an example from the GENPOD trial.
od: Wiles, N, i wsp.
Wydane: (2014)

Sixty years of placebo-controlled antipsychotic drug trials in acute schizophrenia: Systematic review, Bayesian meta-analysis, and meta-regression of efficacy predictors.
od: Leucht, S, i wsp.
Wydane: (2017)

Sixty years of placebo-controlled antipsychotic drug trials in acute schizophrenia: systematic review, Bayesian meta-analysis, and meta-regression of efficacy predictors
od: Leucht, S, i wsp.
Wydane: (2017)

Efficacy and Safety of Low-Dose Brexpiprazole for Acute Schizophrenia: Meta-Analysis of Randomized Placebo-Controlled Trials
od: Zhao M, i wsp.
Wydane: (2022-08-01)

Risperidone versus placebo for aggression following traumatic brain injury: a feasibility randomised controlled trial
od: Paul Bassett, i wsp.
Wydane: (2020-09-01)

The MATISSE study: a randomised trial of group art therapy for people with schizophrenia
od: Crawford Mike J, i wsp.
Wydane: (2010-08-01)

Disconnection of drug-response and placebo-response in acute-phase antipsychotic drug trials on schizophrenia? Meta-regression analysis
od: Leucht, S, i wsp.
Wydane: (2019)

Adjunctive simvastatin treatment in schizophrenia patients; a double blind randomized and placebo controlled trial
od: Somaieh Ashrafi, i wsp.
Wydane: (2022-01-01)

Placebo response rates in antidepressant trials: a systematic review of published and unpublished double-blind randomised controlled studies
od: Furukawa, T, i wsp.
Wydane: (2016)

Reactions to treatment debriefing among the participants of a placebo controlled trial
od: Crawford Fay, i wsp.
Wydane: (2005-04-01)

Placebo-controlled trial of cytisine for smoking cessation.
od: West, R, i wsp.
Wydane: (2011)

The debate over placebo-controlled trials.
od: Frankllin Miller
Wydane: (2005-06-01)

The debate over placebo-controlled trials.
Wydane: (2005-06-01)

The clinical effectiveness and cost effectiveness of clozapine for inpatients with severe borderline personality disorder (CALMED study): a randomised placebo-controlled trial
od: Mike J. Crawford, i wsp.
Wydane: (2022-04-01)

Efficacy and tolerability of lurasidone in schizophrenia: A systematic review and meta-analysis of short-term, randomized, placebo controlled trials
od: K. Hagi, i wsp.
Wydane: (2021-04-01)

5-HT3 antagonist for cognition improvement in schizophrenia: a double blind, placebo-controlled trial
od: Neyousha Mohammadi, i wsp.
Wydane: (2010-01-01)

5-HT3 antagonist for cognition improvement in schizophrenia: a double blind, placebo-controlled trial
od: Neyousha Mohammadi, i wsp.
Wydane: (2010-01-01)